SPEAKERS
KEYNOTES
Day Two Keynote
Eric Winer, MD
Yale School of Medicine
Alfred Gilman Professor of Pharmacology and Professor of Medicine (Medical Oncology)
Director, Yale Cancer Center; President and Physician-in-Chief, Smilow Cancer Hospital; Deputy Dean for Cancer Research, Yale School of Medicine
SPEAKERS
-
Jonathan P. Gertler
Back Bay Life Science Advisors
Managing Partner, Chief Executive Officer -
Theodore Jadick
DNB Carnegie, Inc.
President, Chief Executive Officer -
Renée Aguiar Lucander
Hansa BioPharma
Chief Executive Officer -
James Cirenza
DNB Carnegie, Inc.
Managing Director -
Kristoffer Nordström
XVIVO
CFO/SVP Corporate Strategy & Business Development -
Theresa Agnew
BioGaia
President, Chief Executive Officer -
Gregory Benning
Back Bay Life Science Advisors
Managing Director, Head of Investment Banking -
Peter Bak
Back Bay Life Science Advisors
Managing Director -
Torbjörn Sköld
Bonesupport
Chief Executive Officer -
Clarke B. Futch
HCRx
Chairman, Chief Executive Officer -
Ahmed Mousa
Vicore Pharma
Chief Executive Officer -
David Bejker
Affibody
President, Chief Executive Officer -
Francesco Maria Lavino
F2G
Chief Executive Officer -
Todd Davis
Ligand Pharma
Chief Executive Officer -
Thomas Feldthus
Saniona
Co-Founder, Chief Executive Officer -
Martin Welschof
BioInvent
Chief Executive Officer -
Mark Gaffney
Calluna Pharma
Chief Executive Officer -
Geir Hiller Holom
DNB Carnegie
Financial Analyst -
Adam Lang
Gubra
Head of Investor Relations -
Karl Hård
Egetis Therapeutics
Head of Investor Relations and Business Development -
Anders Hjort
Bavarian Nordic
Vice President, Head of Investor Relations -
Glenn Rewick
Flagship Pioneering
Senior Partner, Value Realization -
Rune Majlund Dahl
DNB Carnegie
Managing Director